{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "11383613", "DateCompleted": {"Year": "2001", "Month": "10", "Day": "18"}, "DateRevised": {"Year": "2020", "Month": "12", "Day": "08"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "0009-2363", "JournalIssue": {"Volume": "49", "Issue": "5", "PubDate": {"Year": "2001", "Month": "May"}}, "Title": "Chemical & pharmaceutical bulletin", "ISOAbbreviation": "Chem Pharm Bull (Tokyo)"}, "ArticleTitle": "Effect of mirabilitum in formularization: change of prolyl endopeptidase inhibitory activity and of constituents using the preparation method of Tokaku-joki-to.", "Pagination": {"StartPage": "595", "EndPage": "600", "MedlinePgn": "595-600"}, "Abstract": {"AbstractText": ["To clarify the effect of Mirabilitum in formularization, change of prolyl endopeptidase inhibitory activity and of constituents using the preparation method of a Kampo formula Tokaku-joki-to ([Japanese characters: see text], Persia and Rhubarb combination) was examined by the liquid chromatography-mass spectroscopy (LC-MS) method. Mirabilitum under boiling condition caused qualitative and quantitative change of the constituents through hydrolysis which caused a change of its activity. This was considered to be the main reason the classical Chinese medical book \"Shang han lun ([Japanese characters: see text])\" specified that Mirabilitum should be added at a later stage of decoction."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Natural Medicine, Toyama Medical and Pharmaceutical University, Sugitani, Japan."}], "Identifier": [], "LastName": "Fan", "ForeName": "W", "Initials": "W"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Tezuka", "ForeName": "Y", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kadota", "ForeName": "S", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Japan", "MedlineTA": "Chem Pharm Bull (Tokyo)", "NlmUniqueID": "0377775", "ISSNLinking": "0009-2363"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}, {"RegistryNumber": "0", "NameOfSubstance": "Protease Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Sulfates"}, {"RegistryNumber": "0", "NameOfSubstance": "tokaku-joki-to"}, {"RegistryNumber": "0YPR65R21J", "NameOfSubstance": "sodium sulfate"}, {"RegistryNumber": "EC 3.4.21.-", "NameOfSubstance": "Serine Endopeptidases"}, {"RegistryNumber": "EC 3.4.21.26", "NameOfSubstance": "Prolyl Oligopeptidases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Chromatography, High Pressure Liquid"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Mass Spectrometry"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Prolyl Oligopeptidases"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protease Inhibitors"}, {"QualifierName": [], "DescriptorName": "Reference Standards"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rheum"}, {"QualifierName": ["metabolism"], "DescriptorName": "Serine Endopeptidases"}, {"QualifierName": [], "DescriptorName": "Spectrophotometry, Ultraviolet"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Sulfates"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "6", "Day": "1", "Hour": "10", "Minute": "0"}, {"Year": "2001", "Month": "10", "Day": "19", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "6", "Day": "1", "Hour": "10", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11383613", "10.1248/cpb.49.595"]}}], "PubmedBookArticle": []}